Analysts on Wall Street Lower Ratings for These 10 Stocks

In this article, we will discuss the 10 stocks recently downgraded by analysts.

On August 23, stocks and bonds rose as economic data supported the idea that major central banks might halt interest rate increases to avoid a recession. Before Nvidia Corp.’s earnings report, there were notable gains in the stock market, primarily driven by the performance of major tech companies. Additionally, a US government report suggested that the downward revision of job growth in the year leading up to March might be around 306,000 jobs, a smaller correction than some economists had predicted. In response to data indicating limited customer demand, US business activity saw minimal expansion, causing two-year Treasury yields to decrease by 10 basis points, falling below 5%. Simultaneously, the 10-year German interest rate declined due to a heightened contraction in private-sector activity across the euro area. US new-home sales surged in July, reaching the highest point in more than a year due to ongoing advantages for homebuilders caused by limited supply in the resale market. Purchases of new single-family homes notably grew by 4.4% last month, totaling an annualized rate of 714,000, although this figure was adjusted downward for previous months. Government data released on Wednesday revealed these figures, surpassing the median prediction of 703,000 in a Bloomberg survey of economists. Furthermore, a gauge of backlogs saw a reduction, hitting its lowest level for this year.

According to a report from CNBC, economic conditions in Europe have worsened, with recent data indicating the lowest levels since April 2013, excluding Covid-affected months. The eurozone, comprised of 20 nations sharing the same currency, grew 0.3% in Q2 and 0.1% in Q1. Analysts polled by Refinitiv predict that the European Central Bank will likely maintain its current main rate of 3.75%. Business activity in Europe contracted further in August, reaching its lowest point since November 2020. The flash composite purchasing managers’ index for the eurozone fell to 47.0 in August from July’s 48.6, missing the expected 48.8. Figures above 50 signify growth, while figures below 50 indicate contraction. Excluding Covid-impacted months, this data indicates the weakest reading since April 2013. Cyrus de la Rubia, Chief Economist at Hamburg Commercial Bank, noted that the service sector’s decline matches the struggling manufacturing performance. The services PMI hit a 30-month low at 48.3, while manufacturing PMI slightly improved from 42.7 in July to 43.7 this month. Based on PMI figures, Rubia projected a 0.2% contraction for the eurozone in Q3. The region’s growth was 0.3% in Q2 and 0.1% in Q1, influenced by higher interest rates, energy costs, and subdued external demand. Differences within the region are evident, with Germany experiencing a significant business activity decline in August. This data shapes discussions on the European Central Bank’s upcoming decisions. After the July meeting, President Christine Lagarde suggested potential rate hikes or pauses hinging on new data.

On the stocks market front, notable stocks such as Target Corporation (NYSE:TGT) and Certara, Inc. (NASDAQ:CERT) were downgraded by analysts, among many others. Check out the complete article to see some other stocks recently downgraded by analysts.

10. Insulet Corporation (NASDAQ:PODD)

Price Reaction after the Downgrade: +1.22 (+0.62%)

On August 21, Baird downgraded Insulet Corporation (NASDAQ:PODD) rating from “Outperform” to “Neutral” and lowered the price target from $320 to $219. This change follows a survey of 25 endocrinologists who were asked about the use of GLP-1 in type two diabetes management. The downgrade reflects a more cautious outlook based on insights from the survey, suggesting a potential shift in Insulet Corporation market dynamics and growth prospects.

The Ithaka Group made the following comment about Insulet Corporation in its second quarter 2023 investor letter:

“Insulet Corporation (NASDAQ:PODD) is a medical device company focused on the design, development and commercialization of insulin pump systems for people with type 1 diabetes. Diabetes is a chronic, life-threatening disease for which there is no known cure. Insulet’s insulin pump system is superior to traditional multiple daily injections because it provides its users with a more accurate and pain free way to administer insulin when compared to injecting it via syringe multiple times per day. Insulet’s stock was under pressure following news that Medtronic purchased EOFlow, the manufacturer of the EOPatch, a tubeless, wearable and fully disposable insulin delivery device. While the EOPatch is not yet launched in the US, it is widely believed it will be available by the end of 2024, increasing competitive pressure on Insulet.”

09. Kanzhun Limited (NASDAQ:BZ)

Price Reaction after the Downgrade: 0.00 (0.00%)

Kanzhun Limited (NASDAQ:BZ) runs BOSS Zhipin, an online job search platform that connects job seekers with employers. The company generates revenue by providing recruitment services to job seekers and enterprise clients through its mobile apps and websites. On August 22, Macquarie analyst Danny Lee significantly adjusted his stance on Kanzhun Limited. Previously having held an ‘outperform’ rating for the company, Lee has now revised his recommendation to ‘neutral’. This modification could indicate a shift in Lee’s assessment of Kanzhun’s future performance and market dynamics. Such changes in analyst recommendations can carry substantial implications for investors as they reflect the evolving perceptions and insights within the financial industry. Similar to Target Corporation and Certara, Inc., Kanzhun Limited is yet another stock that has recently faced analyst downgrades.

08. Xcel Energy Inc. (NASDAQ:XEL)

Price Reaction after the Downgrade: -0.01 (-0.02%)

Xcel Energy Inc. (NASDAQ:XEL) has shown minimal movement in the trading session on August 22 due to an announcement from Bank of America. The bank has decided to downgrade the stock’s rating from ‘Buy’ to ‘Neutral’, accompanied by a notable adjustment in the price target. Previously set at $72, the new target now is $60. This decision comes in light of recent challenges faced by Xcel Energy Inc. in regulatory matters within Minnesota and Colorado. These regulatory setbacks could have impacted the company’s operational outlook and strategic trajectory. Additionally, the potential liabilities associated with wildfires have raised concerns, prompting a reevaluation of the stock’s investment potential. Bank of America’s rating change highlights their reassessment of Xcel Energy Inc. short to mid-term prospects. The shift from a ‘Buy’ to a ‘Neutral’ recommendation could reflect Bank of America’s view that the stock’s previous upside potential might now be more tempered due to the regulatory hurdles and potential financial risks linked to wildfire liabilities.

07. Alpha Metallurgical Resources, Inc. (NYSE:AMR)

Price Reaction after the Downgrade: -1.50 (-0.77%)

On August 21, TD Cowen analyst Lance Vitanza downgraded Alpha Metallurgical Resources, Inc. (NYSE:AMR), moving from an ‘Outperform’ to a ‘Market Perform’ rating, lowering the price target from $200 to $194. This shift led to around 0.77% drop in Alpha Metallurgical Resources, Inc. stock on August 22. Vitanza cited the company’s recent substantial surge in value, alongside weaker global economic growth affecting demand for finished steel products and coking coal indices. Despite acknowledging Alpha Metallurgical Resources, Inc. strong management and prudent cash flow distribution, Vitanza’s decision was influenced by the significant reduction in the gap between the stock price and the value determined through discounted cash flow analysis. Much like Target Corporation and Certara, Inc., Alpha Metallurgical Resources, Inc. is now part of the group of companies experiencing recent analyst downgrades. This occurrence suggests a broader trend where analysts are reassessing their outlook on various stocks.

06. Genpact Limited (NYSE:G)

Price Reaction after the Downgrade: -0.39 (-1.07%)

On August 22, a significant alteration emerged in the evaluation of Genpact Limited (NYSE:G) by an analyst from JPMorgan. Previously maintaining a ‘neutral’ rating on the stock, the analyst has now opted for a more cautious stance by downgrading it to an ‘underweight’ rating. This adjustment in the analyst’s perspective could suggest a heightened concern about the stock’s near-term performance and the potential challenges it might face.

In conjunction with this change in rating, the JPMorgan analyst has introduced a new price target of $40. This figure indicates the level at which they anticipate the stock to perform in the future, and it is notably lower than the stock’s current trading value. Establishing this new price target reflects the analyst’s recalibration of their expectations for Genpact Limited value and growth trajectory.

Vulcan Value Partners made the following comment about Genpact Limited in its second quarter 2023 investor letter:

“We purchased two new positions during the quarter: Genpact Limited (NYSE:G) and Dun & Bradstreet Holdings Inc. Genpact is an IT services company that was spun out of General Electric several years ago. Genpact focuses on business process outsourcing (BPO) and technology digitalization markets. It has a diverse client base that is spread across multiple industries. Complexity within the IT space is growing rapidly, and Genpact plays an important role in helping customers navigate the complexity. We have owned Genpact in the past and are happy to have the opportunity to own it once again.”

05. Target Corporation (NYSE:TGT)

Price Reaction after the Downgrade: -2.85 (-2.23%)

On August 22, Daiwa Securities executed a significant adjustment in its assessment of Target Corporation, a notable retail company. Previously maintaining an ‘Outperform’ rating for Target Corporation, Daiwa Securities has opted to lower this rating to ‘Neutral’. The firm has substantially reduced its previously set price target for the stock, bringing it down from $163.00 to $134.00. These recommendation and price target changes directly respond to Target Corporation Q2 earnings announcement. Target Corporation Q2 earnings report revealed an EPS Normalized Actual of $1.80, surpassing expectations by $0.38. However, the company’s revenue for the same period stood at $24.77 billion, falling short of expectations by $458.66 million.

Daiwa Securities’ decision to downgrade Target’s rating and adjust its price target may have been influenced by the mixed results in the Q2 earnings report. While Target exceeded earnings per share estimates, the revenue figures missed expectations. Such a scenario could prompt a reassessment of the stock’s investment potential, reflecting concerns about the company’s revenue growth and overall market performance.

Smead Value Fund made the following comment about Target Corporation in its second quarter 2023 investor letter:

“Our biggest detractors were Target Corporation (NYSE:TGT), Warner Brothers (WBD), and Pfizer (PFE). Target was our worst performer in the quarter, primarily driven by customers and public reaction to in-store promotions for the month of June. We believe management has listened to its core customers, made the necessary changes, and avoided structural damage to the brand.”

04. Certara, Inc. (NASDAQ:CERT)

Price Reaction after the Downgrade: -0.44 (-2.73%)

Certara, Inc. experienced a decline in its stock price on August 22 following a downgrade by Jefferies. The investment firm adjusted its rating on Certara, Inc. from ‘Buy’ to ‘Hold’. The rationale for this decision was rooted in a reduced expectation of growth for the health technology company in the upcoming year, specifically in 2024. The catalyst for this downgrade seems to be the CFO of Certara, Inc., John Gallagher, who presented a less optimistic near-term outlook for the company during an investor presentation. Gallagher’s assessment likely cast uncertainty on the company’s immediate future, prompting Jefferies to reconsider its positive stance on Certara, Inc. stock.

Such adjustments in analyst ratings often carry weight in the market, reflecting expert opinions on a company’s growth prospects and potential challenges. The downgrade from ‘Buy’ to ‘Hold’ suggests Jefferies now sees a more subdued outlook for Certara, Inc. stock, potentially impacting investor sentiment and trading behavior.

03. Medical Properties Trust, Inc. (NYSE:MPW)

Price Reaction after the Downgrade: -0.24 (-3.42%)

On August 21, JPMorgan significantly adjusted its evaluation of Medical Properties Trust, Inc. (NYSE:MPW). The company’s rating has been downgraded from ‘Neutral’ to ‘Underweight’. With this shift, JPMorgan has revised the price target for Medical Properties Trust, Inc. downward. The previously set target of $9 has been adjusted to $7. This alteration in rating and price target reflects JPMorgan’s revised outlook on the investment potential of Medical Properties Trust, Inc.. The shift to an ‘Underweight’ rating implies that the firm believes the stock’s performance might be below average compared to other investment opportunities. The adjusted price target of $7 indicates JPMorgan’s projection of where the stock’s value might stabilize.

Miller Value Partners Income Strategy made the following comment about Medical Properties Trust, Inc. in its second quarter 2023 investor letter:

“Medical Properties Trust, Inc. (NYSE:MPW) gained after it reported 1Q23 revenues of $350.2MM, -14.5% Y/Y, below consensus of $352.5MM, and Normalized Funds from Operations (FFO)/share of $0.37, -21.3% Y/Y, slightly below consensus of $0.38. The company’s CEO noted “The terms of recently announced transactions including Springstone, the acquisition by CommonSpirit of Steward’s Utah operations, Healthscope, and Prime, have valued our hospital investments near and in excess of our original purchase prices. This confirmation of our underwritten asset values by sophisticated market participants, as well as our existing liquidity and prudently planned debt structure, position us to have no debt maturities until 2025.” The REIT saw a modest uptick in leverage during the quarter, with the company’s Adjusted Net Debt to Annualized Earnings Before Interest, Taxes, Depreciation, and Amortization for Real Estate (EBITDAre) ratio standing at 6.5x as of quarter-end, compared to 6.4x as of 12/31/22. Management maintained its quarterly dividend of $0.29/share, or a 12.5% annualized yield. Management updated full-year 2023 (FY23) guidance for Normalized FFO/share of $1.56 (vs. prior guidance for $1.58), implying a P/FFO multiple of 5.9x, to account for the impact of announced deleveraging asset sales (and expected $1.4B in debt reduction).”

02. Sarcos Technology and Robotics Corporation (NASDAQ:STRC)

Price Reaction after the Downgrade: -0.0700 (-5.83%)

Sarcos Technology and Robotics Corporation (NASDAQ:STRC) experienced a decline of approximately 5% in pre-market trading on August 21. This drop came in response to a downgrade by Jefferies. The reason for the downgrade was cited as “extremely limited” visibility regarding the prospects of the advanced robotic systems company. In light of this lack of visibility, Jefferies lowered its recommendation on Sarcos Technology and Robotics Corporation from ‘Buy’ to ‘Hold’. Alongside this change, the agency also substantially adjusted the price target. The previous price target of $4.25 has been significantly revised downward to $1.15.

Jefferies’ downgrade and the subsequent stock movement emphasize the influential role of expert opinions and analyst ratings in the stock market. The downgrade from ‘Buy’ to ‘Hold’ signifies a shift in sentiment, likely reflecting Jefferies’ concerns about the company’s immediate growth potential. The stark reduction in the price target suggests that Jefferies anticipates a much lower valuation for Sarcos Technology and Robotics Corporation than its previous assessment.

01. Napco Security Technologies, Inc. (NASDAQ:NSSC)

Price Reaction after the Downgrade: -14.87 (-38.71%)

On August 21, Lake Street Capital Markets analyst Jaeson A. Schmidt made significant adjustments to his evaluation of Napco Security Technologies, Inc. (NASDAQ:NSSC). Formerly having a ‘Buy’ rating for the company, Schmidt has opted to lower the rating to ‘Hold’. This shift in perspective is accompanied by a notable reduction in the previously set price target for Napco Security Technologies, Inc.. The earlier price target of $40 has now been revised downward to $30. This adjustment in the price target suggests Schmidt’s recalibration of where the company’s stock value might stabilize in the foreseeable future.

The decision by Lake Street Capital Markets to downgrade Napco Security Technologies, Inc. to ‘Hold’ likely reflects Schmidt’s assessment of the company’s immediate growth prospects and market dynamics. The shift from a ‘Buy’ rating to a ‘Hold’ rating suggests that Schmidt believes the stock’s potential performance might be more subdued than his previous assessment.

Wasatch Global Investors made the following comment about Napco Security Technologies, Inc. in its Q3 2022 investor letter:

“Another meaningful contributor was Napco Security Technologies, Inc. (NASDAQ:NSSC). The company offers electronic security systems for access control, alarm warnings and video surveillance. With component prices elevated because of supply-chain constraints, Napco chose to temporarily sacrifice gross margins on its systems hardware in order to take market share from competitors. This strategy has now paid off in the form of higher-margin recurring revenues from the company’s growing installed base. Meanwhile, Napco has boosted hardware profitability through strategic price increases and improvements to the supply chain as demand remains strong, particularly in its school-security business.”

You can also take a look at Ken Fisher’s Top 15 Energy Stock Picks and 10 Best Dividend Stocks Yielding at Least 7% According to Hedge Funds.

Suggested Articles:

• Billionaire Ray Dalio’s Top 12 Dividend Stock Picks
• Billionaire Ken Fisher’s Top 15 Dividend Stock Picks
• 15 Best Performing Stocks in the Last 6 Months

This article is originally published at Insider Monkey.